Jen Psaki Says Biden Administration Providing Migrant

New Post Public Reply Private Reply Replies (2) Message Board
toodles toodles #83042
280
Jen Psaki Says Biden Administration Providing Migrant Infants Baby Formula amid Shortage Is 'Morally Right

The Biden Administration is standing by its decision to support migrant families at the border amid the nationwide baby formula shortage.On Friday, White House press secretary Jen Psaki addressed recent criticism from Rep. Kat Cammack, Florida Republican lawmaker, and other republicans who have publicly criticized President Joe Biden for providing baby formula to immigrant children.
Psaki pointed out that the actions are in line with the law, citing the Flores Settlement Agreement, which has been followed by every administration. The law stems from a class action lawsuit settled by the U.S. Justice Department under the Bill Clinton administration, in 1997.

As part of a settlement, the federal government is required to provide migrant children with facilities that have "access to toilets and sinks, drinking water and food as appropriate, medical assistance if the minor is in need of emergency services," and other necessities.

"We also think it's morally the right thing to do," she said during a press briefing. "It is the law. But we believe that when children and babies, or babies I should say, are crossing the border with a family member, that providing them formula is morally right. And so, we certainly support the implementation of it."

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories.

On Friday, White House press secretary Jen Psaki addressed recent criticism from Rep. Kat Cammack, Florida Republican lawmaker, and other republicans who have publicly criticized President Joe Biden for providing baby formula to immigrant children.

Linoleum Flooring Marmoleum Fresco Turquoise By Forbo
Ad
Ad
Green Building Supply
Linoleum Flooring Marmoleum Fresco Turquoise By Forbo
Psaki pointed out that the actions are in line with the law, citing the Flores Settlement Agreement, which has been followed by every administration. The law stems from a class action lawsuit settled by the U.S. Justice Department under the Bill Clinton administration, in 1997.

As part of a settlement, the federal government is required to provide migrant children with facilities that have "access to toilets and sinks, drinking water and food as appropriate, medical assistance if the minor is in need of emergency services," and other necessities.

"We also think it's morally the right thing to do," she said during a press briefing. "It is the law. But we believe that when children and babies, or babies I should say, are crossing the border with a family member, that providing them formula is morally right. And so, we certainly support the implementation of it."


RELATED: Moms Turn to Social Media, Drive Miles for Products amid Baby Formula Shortage: 'It's Very, Very Scary'

Retailers nationwide are experiencing a shortage of baby food formula that worsens each day, with new data by Datasembly showing the national out-of-stock rate hit a high of 43 percent for the first week of May.

While the shortages of some formulas first emerged late last year, amid the pandemic, they've worsened in recent months due to challenges with the supply chain, product recalls by some American manufacturers and inflation.

Biden is taking steps to ameliorate effects of the shortage, the White House said Thursday, after Abbott Nutrition, the nation's largest manufacturer of infant formula, recalled products made in a Michigan plant back in late February due to possible contamination of cronobacter and salmonella.

Abbott Nutrition released a statement Friday, outlining steps it has taken since February to "get as much product into the hands of parents as we can."

"We understand the situation is urgent — getting Sturgis up and running will help alleviate this shortage," the company said. "Subject to FDA approval, we could restart the site within two weeks."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading